Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted… - BMC psychiatry, 2014‏ - Springer
Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

[HTML][HTML] Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders

N Singewald, C Schmuckermair, N Whittle… - Pharmacology & …, 2015‏ - Elsevier
Pathological fear and anxiety are highly debilitating and, despite considerable advances in
psychotherapy and pharmacotherapy they remain insufficiently treated in many patients with …

[کتاب][B] Exposure therapy for anxiety: Principles and practice

JS Abramowitz, BJ Deacon, SPH Whiteside - 2019‏ - books.google.com
Now revised and expanded to include cutting-edge acceptance-based techniques and a
new focus on inhibitory learning, this is the leading guide to therapeutic exposure, a crucial …

Psychopharmacological treatment of obsessive-compulsive disorder (OCD)

A Del Casale, S Sorice, A Padovano… - Current …, 2019‏ - ingentaconnect.com
Background: Obsessive-compulsive disorder (OCD) is associated with affective and
cognitive symptoms causing personal distress and reduced global functioning. These have …

D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: a systematic review …

D Mataix-Cols, LF De La Cruz, B Monzani… - JAMA …, 2017‏ - jamanetwork.com
Importance Whether and under which conditions D-cycloserine (DCS) augments the effects
of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and …

Obsessive-compulsive disorder

JS Abramowitz, S Taylor, D McKay - The Lancet, 2009‏ - thelancet.com
Obsessive-compulsive disorder is a severe and disabling clinical condition that usually
arises in late adolescence or early adulthood and, if left untreated, has a chronic course …

[PDF][PDF] Practice guideline for the treatment of patients with obsessive-compulsive disorder

American Psychiatric Association, LM Koran… - 2007‏ - academia.edu
PRACTICE GUIDELINE FOR THE TREATMENT OF PATIENTS WITH OBSESSIVE-COMPULSIVE
DISORDER Page 1 Not for Distribution or Citation Draft 2, December 6, 2005 PRACTICE …

Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment

C Pittenger, MH Bloch, K Williams - Pharmacology & therapeutics, 2011‏ - Elsevier
Obsessive compulsive disorder is prevalent, disabling, incompletely understood, and often
resistant to current therapies. Established treatments consist of specialized cognitive …

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic …

B Bandelow, J Zohar, E Hollander… - The World Journal of …, 2008‏ - Taylor & Francis
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit

MR Milad, SC Furtak, JL Greenberg… - JAMA …, 2013‏ - jamanetwork.com
Importance Obsessive-compulsive disorder (OCD) may be characterized by impaired self-
regulation and behavioral inhibition. Elevated fear and anxiety are common characteristics …